Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices 50437 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Musculoskeletal Rehabilitation 

Sciences. 

Date: December 1, 2017. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Maria Nurminskaya, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, Bethesda, MD 20892, (301) 435–1222, 

nurminskayam@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurodevelopment. 

Date: December 1, 2017. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Afia Sultana, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Room 4189, Bethesda, MD 

20892, (301) 827–7083, sultanaa@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Cancer 

Health Disparities PAR Review. 

Date: December 4–5, 2017. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Ola Mae Zack Howard, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, 301–451– 

4467, howardz@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Virology. 

Date: December 4, 2017. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Neerja Kaushik-Basu, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, (301)435– 

2306, kaushikbasun@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Virology. 

Date: December 4, 2017. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Susan Daum, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Dr., Room 3202, 

Bethesda, MD 20892, 301–827–7233, 

susan.boyle-vavra@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 26, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–23639 Filed 10–30–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Infectious 

Diseases, Reproductive Health, Asthma and 

Pulmonary Conditions: Small Grant 

Mechanisms. 

Date: November 14, 2017. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Lisa Steele, Ph.D., 

Scientific Review Officer, PSE IRG, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, 301–594– 

6594, steeleln@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Mechanisms of Disparities in Chronic Liver 

Diseases and Cancer. 

Date: November 15, 2017. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Suzanne Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Role of Myeloid Cells in Persistence and 

Eradication of HIV–1 Reservoirs from the 

Brain. 

Date: November 29, 2017. 

Time: 8:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue NW., Washington, DC 

20036. 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3190, Bethesda, MD 20892, 301–827– 

7480. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 16– 

333: Metabolic Contributions to the 

Neurocognitive Complications of Diabetes 

(R01). 

Date: November 30, 2017. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Hui Chen, MD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6164, Bethesda, MD 20892, 301– 

435–1044, chenhui@csr.nih.gov. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
50438 Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: HIV/AIDS Innovative Research 

Applications. 

Date: November 30, 2017. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mark P. Rubert, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1775, rubertm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 26, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–23638 Filed 10–30–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–0194] 

Waterway Suitability Assessment for 

Operation of Liquefied Hazardous Gas 

Terminal; Port Arthur, TX 

AGENCY: Coast Guard, DHS. 

ACTION: Request for comments; 

extension of comment period. 

SUMMARY: We are extending the 

comment period on the subject request 

for comments that we published August 

14, 2017. We are extending the deadline 

by 30 days because interested parties 

indicated the need for additional time to 

respond due to the effects from 

Hurricane Harvey. The comment period 

is now open through November 30, 

2017. 

DATES: Comments and related material 

must be received on or before November 

30, 2017. 

ADDRESSES: You may submit comments 

identified by docket number USCG– 

2017–0194 using the Federal 

eRulemaking Portal at http://

www.regulations.gov. See the ‘‘Public 

Participation and Request for 

Comments’’ portion of the 

SUPPLEMENTARY INFORMATION section 

below for further instructions on 

submitting comments. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this notice, call 

or email Commander Loan T. O’Brien, 

U.S. Coast Guard; telephone 409–723– 

6564, email, Loan.T.O’Brien@uscg.mil. 

SUPPLEMENTARY INFORMATION: The Coast 

Guard is extending the comment period 

on the request for comments entitled 

‘‘Waterway Suitability Assessment for 

Operation of Liquefied Hazardous Gas 

Terminal; Port Arthur, TX’’ that we 

published in the Federal Register on 

August 14, 2017 (82 FR 37887). We are 

extending the comment period by 30 

days to allow interested persons more 

time to comment. You may not submit 

comments through November 30, 2017. 

Public Participation and Request for 

Comments 

We encourage you to submit 

comments and related material in 

response to this notice through the 

Federal eRulemaking Portal at http://

www.regulations.gov. We will consider 

all submissions and may adjust our final 

action based on your comments. If you 

submit a comment, please include the 

docket number for this notice, indicate 

the specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. 

If your material cannot be submitted 

using http://www.regulations.gov, 

contact the person in the FOR FURTHER

INFORMATION CONTACT section of this 

document for alternate instructions. 

Documents mentioned in this notice, 

and all public comments, are in our 

online docket at http://

www.regulations.gov and can be viewed 

by following that Web site’s 

instructions. Additionally, if you go to 

the online docket and sign up for email 

alerts, you will be notified when 

comments are posted or a final rule is 

published. To view comments, go to 

http://www.regulations.gov, type the 

docket number ‘‘USCG–2017–0194’’ in 

the ‘‘SEARCH’’ box and click 

‘‘SEARCH.’’ Click on ‘‘Open Docket 

Folder’’ on the line associated with this 

notice and request for comments. We 

accept anonymous comments. All 

comments received will be posted 

without change to http://

www.regulations.gov and will include 

any personal information you have 

provided. For more about privacy and 

the docket, you may review a Privacy 

Act notice regarding the Federal Docket 

Management System in the March 24, 

2005, issue of the Federal Register (70 

FR 15086). 

Dated: October 25, 2017. 

Jaqueline Twomey, 

Captain, U.S. Coast Guard, Captain of the 

Port, Port Arthur. 

[FR Doc. 2017–23578 Filed 10–30–17; 8:45 am] 

BILLING CODE 9110–04–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–6062–N–01] 

Notice of HUD-Held Multifamily Loan 

Sale (MLS 2018–1) 

AGENCY: Office of the Assistant 

Secretary for Housing—Federal Housing 

Commissioner, HUD. 

ACTION: Notice of sale of two 

multifamily mortgage loans. 

SUMMARY: This notice announces HUD’s 

intention to sell two unsubsidized 

multifamily mortgage loans, without 

Federal Housing Administration (FHA) 

insurance, in a competitive, sealed bid 

sale on or about November 8, 2017 (MLS 

2018–1 or Loan Sale). This notice also 

describes generally the bidding process 

for the sale and certain persons who are 

ineligible to bid. 

DATES: A Bidder’s Information Package 

(BIP) was made available on October 11, 

2017 on the HUD Web site at 

www.hud.gov/fhaloansales. Bids for the 

loans must be submitted on the bid date, 

which is currently scheduled for 

November 8, 2017 between certain 

specified hours. HUD anticipates that an 

award or awards will be made on or 

before November 9, 2017. Closing is 

expected to take place between 

November 17, 2017 and November 20, 

2017. 

ADDRESSES: To become a qualified 

bidder and receive the BIP, prospective 

bidders must complete, execute, and 

submit a Confidentiality Agreement and 

a Qualification Statement acceptable to 

HUD. Both documents will be available 

on the HUD Web site at www.hud.gov/ 

fhaloansales. Please fax or email as well 

as mail executed original documents to 

JS Watkins Realty Partners, LLC: JS 

Watkins Realty Partners, LLC, c/o The 

Debt Exchange, 133 Federal Street, 10th 

Floor, Boston, MA 02111, Attention: 

MLS 2018–1 Sale Coordinator, Fax: 1– 

978–967–8607, Email: mls2018-1@

debtx.com. 

FOR FURTHER INFORMATION CONTACT: John 

Lucey, Director, Asset Sales Office, 

Room 3136, U.S. Department of Housing 

and Urban Development, 451 Seventh 

Street SW., Washington, DC 20410– 

8000; telephone 202–402–3927. 

Hearing- or speech-impaired individuals 


asabaliauskas on DSKBBXCHB2PROD with NOTICES